Vietnam strives to soon access Russia's potential cancer vaccine

Mr. Kirill Dmitriev, Special Representative of the President of Russia for Foreign Economic and Investment Affairs, General Director of the Russian Direct Investment Fund (RDIF), representing Russia, exchanged cooperation documents with Mr. Ngo Chi Dung, Chairman and General Director of VNVC Vaccine Company, in the presence of Russian President Putin and General Secretary To Lam. Photo: THONG NHAT

The documents signed between the two units were presented at an event within the framework of General Secretary To Lam's official visit to the Russian Federation from May 8 to 11, on the occasion of the 80th anniversary of Victory Day in the Great Patriotic War and the 75th anniversary of the establishment of Vietnam-Russia diplomatic relations.

According to the cooperation agreement, the two sides will discuss to establish a foundation for deep cooperation on high technology in the field of biomedicine, focusing on research, investment, technology transfer and trade of biological drugs and high-tech vaccines. In particular, VNVC's top expectation is to soon bring in a potential cancer treatment vaccine based on mRNA technology that Russia recently announced. In addition, VNVC also signed a cooperation agreement with the Gamaleya National Research Center for Epidemiology and Microbiology on scientific research cooperation and biotechnology development. Research topics will be deployed in the near future.

Also within the framework of cooperation, VNVC also signed with the Russian pharmaceutical group Binnopharm, one of the largest pharmaceutical manufacturers in Russia.

VNVC representative said that immediately after signing, VNVC will start scientific exchange activities with scientists from many research institutes and high-level hospitals in Russia to receive technology transfer for research, testing and production of vaccines using mRNA technology. In particular, research and implementation of vaccine production according to the model of "comprehensive, completely closed cycle" in Vietnam, focusing on pharmaceutical products that are Binnopharm's strengths, along with other important pharmaceutical products of Russia, focusing on the field of high-tech cancer diagnosis and treatment.

According to the cooperation agreement between RDIF and VNVC, potential Russian mRNA technology vaccines will be brought to Vietnam by VNVC soon from the early stage of clinical trials so that patients have the opportunity to access more of the world's leading modern solutions with a very high success rate after treatment. In addition, Russia's implementation of clinical trials of biological drugs and advanced technology vaccines in Vietnam also helps the registration, licensing and commercialization of products more smoothly and quickly once good results are achieved.

This cooperation agreement opens up opportunities for Vietnam to have early and comprehensive access to new Russian research and inventions in the fields of medicine and health care, helping people soon have access to new technology drugs and vaccines such as Russia's potential cancer treatment vaccine using mRNA technology.

Previously, in December 2024, the National Medical Research Center for Radiology under the Russian Ministry of Health announced that the country was researching and developing a potential lung cancer vaccine, produced using advanced mRNA technology.

THANH SON

Source: https://www.sggp.org.vn/viet-nam-no-luc-som-tiep-can-vaccine-ung-thu-tiem-nang-cua-nga-post794740.html